William Levin, MD
University of Pennsylvania Cancer Center
Last Modified: November 7, 2001
Presenter: J.H. Simon
Presenter's Affiliation: University of Iowa, Iowa City
Type of Session: Scientific
Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood, with about 400 new cases per year. Five year survival rates are around 70%. Unfortunately, adults with rhabdomyosarcoma have a much poorer prognosis. This retrospective study was undertaken to identify the factors responsible for poor outcome.
Overall prognosis of adult rhabdomyosarcoma in adults is worse than reported in children. Age criteria, within the adult population did not further classify outcome. Adult disease is more common in the extemities, while more common in the head and neck region in children.
Generalizations from this study are not easily made, given that this is a small retrospective study from a single institution. Nevertheless, adults with rhabdomyosarcoma appear to fare less well than their pediatric counterparts
Oncolink's ASTRO Coverage made possible by an unrestricted Educational Grant from Bristol-Myers Squibb Oncology and Pharmacia Oncology.
Dec 19, 2014 - Adults with rhabdomyosarcoma, though rare, have significantly worse long-term survival than children with the disease, although many of the same factors predict survival in both cases, according to a study published online April 27 in the Journal of Clinical Oncology.
Dec 19, 2014
Jun 11, 2013